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Earlier studi es have shown tha t epibo lin , a g lyco pro tein in 
human plasm a, identi ca l to preparations fro m o ther labo-
rato ri es referred to as serulll spreadin g facto r and vitro-
nectin , requires a second plasm a acti vity in o rder to suppo rt 
m axim al primary epidermal cell spreadin g . This plasm a 
fraction , referred to as coepibo lin , alone supports no cell 
spreading but po tentiates th e acti vity of epibolin by at leas t 
5-10 times . Studies reported here indica te that coepibolin 
activit y associates w ith one plasma fra cti on, it ca nn o t be 
substituted by commercial preparations o f ovalbull1in , soy-
I t has lo ng been recogni zed th at pl as m a cont:l in s a pro pert y th at supp o rts the adh es io n and spreadin g o f cell s in ti ss ue culture. Fo r m ature, fres hl y iso13tcd epiderm al cell s, o ne of th ose fun ctio ns has bee n purified and ide ntified as a 65 k D glycoprotein te rmed epibolin [1 ,2]. Recent studies have shown 
th at epibo lin appea rs to bc identica l to preparati ons put fo rth by 
o thcr labo rato ries and referred to as serum spreadin g facto r [3], 
vitro nectin [4] and S-pro tein 15 1. 
In th e initi al isolati on stud ies, it was fo un d that the specifi c 
spreadin g ac ti vity o f crude epibo lin did no t incre:lse after the 
D EAE chro matog raph y step , even th o ugh in acti ve pro tein was 
rem oved [1] . M ax im al specifi c acti vity was recove red , however , 
upon addin g th e in ac tive di sca rd frac tio n fw m thi s step to th e 
assay. Since the d isca rd frac ti o n alone did not suppo rt cell spread-
in g, it w as ass um ed that thi s fract io n contained an acti vity po-
tenti atin g that o f epibo lin. This ac ti vit y was referred to as co-
epibolin . T he present studies were co ndu cted to furth er charac-
te ri ze th e coepibo lin ac ti v ity o f plas m a rl nd to pro be its poss ibl e 
m echanism o f acti o n . These studies show that coep ibolin acti vity 
is no t a fun cti o n of:l ll pro teins and th:lt it purifi es w ith albumin . 
Its actio n appears to m odi fy th e m o rph o logy of epibolin-indu ced 
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Abbreviatio ns: 
BSA: bovine se rum albumin 
Con A: conca nava lin A 
D M EM : D ulbecco's mod ified Eag le's med ium 
H SA: human serum albumin 
PAGE : po lyacrylamide gel elect rophores is 
P- bu ffe r: 50 mM N aH, PO.,I N a, l-II'O ." pH 6.0 
STI: soy bean trypsin inhibito r 
bean tryps'in inhibito r, o r hemoglobin , but it can be sub-
stituted by co lllm ercial bovine or hum an serum albumin. 
Th e activity purified to electrophoreti c ho m ogeneity co-
mig rates w ith , and shows antigenic properties of albumin. 
Under the assay conditi ons coepibo lin affects the extent 
and m orph ology o f cell spreading : in the presence of epi-
bo lin plus coepibo lin cell s assume a more polar o rientation 
than in epibolin alone. For its m ax im al effect coepibo lin 
must be present continuously in th e ea rl y ph ases of cell 
spreading. J II/ vest DCI'matol 89:59- 63, 1987 
epiderm al cell spreadin g, and it a ppea r~ to be needed by th e cells 
continuo usly in o rder to prod LI ce an effect. 
MATE RIALS AN D M ETH O D S 
Cell Spreading Assay The di rect spreadin g activity of all plasm a 
frac tio ns was assayed usin g trypsin-dissociated guinea pig epi-
derm al cell s as previo usly desc ribed [2]. T o ass ure neutrali za tion 
of res idual trypsin the cells were rinsed once in a soluti on o f 
D ulbecco's m od ified E ao-Ie's m edium (DME M , G IBCO, G rand 
Isbnd, N ew Yo rk) anci"'soy bean trypsin inhibito r (ST I) (Sig ma 
C hemi ca l Co., St. Louis, Misso uri ) 1. 0 mg/ml. Approximatel y 
2 x 105 ce Ll s suspended in DMEM were add ed to tissue cu lture 
Petri dishes (Co rnin g 34 x 10 ml11) con ta ining D M E M plus an 
appro pri ate dilutio n of the pro tein fraction to be assayed. After 
4-h incubation (37°C , 95% airl5% CO~, H 20 saturated) and Giemsa 
staining [6]. the percent o f spread cells (number of spread cell s 
per 100 attached cell s) was qu antitated microsco picall y . A cell 
was considered to be spread if its cyto pl as m showed a radial or 
po lar patte rn [71. T he coepibolin activity o f a preparation was 
assayed by adding that fraction to culture m ed ium containing 
epibo lin at a limitin g concentrati on th at alone did not support 
signifi cant epiderm al cell spreadin g at 4 h. M aximal cell spreadin g 
was defin ed as the percent of cells spreading in the presence o f 
10% te tal ca lf serum . Under these conditi ons 40-60% of the 
adh erellt cells showed cytopl as mi c spre:lding . O ne spreadin g unit 
was defm ed as the percent o f spread cell s (a t 4 h) per milli gram 
of protein assayed . 
Protein Purification All chemica ls wei'e o f reagent g rade pur-
chased fro m loca l suppliers. Water w as sin gly distilled . All buffe rs 
contained 0 .02% N aN 3, 0 .1 111M phen ylmethy lsulfony l Au oride 
(S ig m a) (diluted fro m a 0. 1 M stock so lutio n in iso pro pyl alcohol), 
20 m M E-amino capro ic acid , and 20 111M thioglycoll ate (S igm a) . 
Bovine serum albumin (B SA, A4503), hum an serum albumin 
(H SA, A95 11 ), transferrin , ova lbumin , hem oglo bin , and STI were 
purchased (S ig m a). Hig hl y purified H SA w as also purchased 
(Calbi ochem 126658; Ca lbiochem, Sa n Diego, Ca lifo rni a) . D i-
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alys is bags were prepa red as described [1]. U sin g BSA as th e 
stand ard , pro tein concentratio ns were determined by th e m ethod 
o f Lowry et al [8]. 
Plasma was fract ionated at 4°C as described [1 '1 with minor 
changes . BrieRy, to 100 ml of fresh human plas m a collected from 
normal dono rs (Yale-New H aven Blood Bank. N ew Haven, 
Conn ecti cut , within 1 week of bleedin g) and clea red by centri-
fu gatio n (5000 .r? for 20 min) (Beckma n J 6-B centrifuge) was 
added 50 ml of s,lturated (N H.lhSO" w ith slow stirrin g for 1 h . 
The precipitate was coll ected by centrifuga ti on (5000 ,f!', 20 min , 
4°C) and discarded. To the supernatant was add ed 150 ml of 
saturated (NH"hSO" (to 2/3 saturation) and mi xed fo r 2 h . Thi s 
precipitate was co llected (5000 g, 20 min. 4°C) and res uspended 
in 100 ml of 50 mM NaH2P04/ N a2HPO", pH 6.0 (P-buffer) and 
dialyzed aga inst the sam e (2 X 4 lite rs, 4°C, 24 h). The di alysa nd 
was poured ove r a D EAE Biogel A (100-200 m es h , BioRad , 
Ri chmo nd , Ca lifo rnia, 8 X 11 cm ) column equilibrated with P-
buffer. The was h efAu ent fractions o f A2HO abso rban ce m o re than 
3.0 were poo led and labeled "coepibolin ." Epibo lin was furt her 
purified by washing the DEAE column retentate w ith P-buffer 
until the A2HO was less th an 0.05 and eluted by step g radi ent w ith 
P-buffer + 100 m M NaCI. The elu ate fra ctio ns of A~HO greater 
than 1.0 were pooied and add ed directl y to a heparin Sepha rose 
column (Pharm acia, Piscataway, N ew Jersey , 2 X 20 cm) pre-
viously eq uilibrated in P-buffer + 100 mM NaC I. The sa mple 
was washed with 100 ml P-buffer + 100 111M N aC I and th en w ith 
50 111M NaH2P04/N a2HPO'1 pH 7.2 + 100 111M NaC I until the 
efAu ent A2HO was less ' th an 0 .05. The ac tive material was eluted 
wi th 50 mM NaH 2P04/ Na2HP04 pH 7.2 + 500 111M N aCI and 
all fractio ns g reater than 0.5 A2HIl abso rpti on we re poo led and 
frozen (- 14°C). The epibolin activity of this preparation is com-
pletely blocked by a m o no clo nal antibody to human epibolin . 
T his antibod y was prepared usin g standard procedures [9], gen-
erated in defined med ium [1 0], and used as the 50% saturated 
amlll o niulll sulfate precipitate after di alys is aga inst 50 111M 
N a2H / N aH 2P04 pH 7.2 + 100 mM N aC I. 
T he fractio n labeled "coepibo lin " above (50 ml approximately 
5 mg pro tein / ml) was furth er purified by titratin g the so luti on 
with 1 N N aO H to pH 8.0 and ap pl yin g it to a DEAE Biogel 
column 4 X 10 CI11 (4°C). which was equilibr:lted to 50 mM 
NaH2/ N a2HPO" pH 8.0. T he loaded colul11n was washed until 
the A2HIl was less th an 0 .1 , then was hed w ith the sa me buffer + 
100 111M N aCI until the A ZHIJ was less th an 0. 1. Coepibolin activity 
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Figure 1. Coepibo lin activity and ge l filtration elution profi le of "co-
epibolin " fraction . Two mi lliliters of the "coepibo lin " preparation (see 
Materials alld Methods) (11 m g/ ml) was loaded o nto a 2 x 80 cm column 
of Sephacryl S 200 (Pharmacia) ;It a Row rate of 10 mUh at 24°C. The 
column was developed with a 20 mM Tris-H C I buffer pH 8.0 plus 1 M 
KC I and inhibi to rs (see Materials alld Methods). The left ordillate reads 
protein concent rati on in A2HIJ units. T he abscissa g ives protein elution tube 
num ber (2 ml fractions) . T he three pro tein peaks were pooled (as indica ted 
by the brackets), labeled A, B , and C. and assayed fo r ce ll spreading (see 
Materials alld Methods). In the assays ep ibo lin concentration was 1-5 p.g/ml 
and the tested cocpibolin fractions 0.5-1. 0 mg/ ml. 
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Figure 2. Coepibo lin ac tivity of va rio us proteins over a concentration 
range (0-2 mg/ml) . Bovine and human scrum albumin (BSA and H SA, 
respectivel y) as well as coc pibo lin (COEP!) dcmonstrated epibolin-en-
han cing ac ti vity. In contrast . ovalbumin (0 VA L ) had no activity. Each 
point is the ave rage of2 experiments counting 200 ce ll s in each. The SEM 
in these ex perim ents was nOt m ore than 10%. In the assays epibo lin 
concentratio ns were 1-5 p.g/ ml. 
was eluted with 50 mM N a2H / N aH zP04 pH 6.0 + 100 111M N aCI. 
(This fra cti on was labeled A50P.) This eluate was immediately 
added to a co ncanava lin A (Con A) Sepha rose co lumn (Pharm acia 
2 X 15 cm) and th e wash collected (this frac tion w as labelled 
A50P-1). T he retained protein eluted w ith 1 M alpha C H J m an-
noside (Si g ma) in the same buffer had no coepibolin activ ity. O ne 
prominent and three faint bands were fOLind after protein elec-
troph o resis of the A50 P- 1 fraction using no ndenaturcd pol y-
acry lamide gel electro pho resis (PAGE) 111] . The bands were elec-
troeluted b y the procedure of Hunkapill er and colleagues [1 21 and 
assayed. That band runnin g with an R,. value of 0.74 in the Davis 
PAGE system was the o nl y o ne with coepibolin activity (A50P-
10). 
Electrophoresis E lectrophoresis was perfo rm ed b y the pro-
cedure o f Davis [11] and Lae mmli [1 3]. Transblo ts w ere per-
fo rmed and stain ed by the m ethod ofTowbin and associates [14] 
usin g nitrocellulose as th e suppo rt , polyclonal rabbit ant ihuman 
alb umin and polycJonal perox idase labeled goat antirabbit anti-
bod y (Cooper Biochemi ca l, M alvern, Pennsylvania), and 4 ch lo-
ron aptho l ~s th e peroxidase substrate [15]. 
Table I. Coepibolin Activity of VarioLis Proteins 
Protein Additive 
Epi (6) 
Epi (40) 
Coepi (350 
Coepi (700) 
BSA (1000) 
HSA (1000) 
Epi (6) + Coepi (350) 
Epi (6) + BSA (1000) 
Epi (6) + HSA (1000) 
E pi (6) + Transferrin (1000) 
Epi (6) + Ova lbumin (1000) 
Epi (6) + Hem oglo bin (1000) 
E pi (6) + STI (1000) 
% Spread Cells 
5 + 3 (5) 
32 ± 1 (3) 
o ± 0 (6) 
o ± 0 (4) 
o ± 0 (5) 
o :±: 0 (5) 
47 ± 3 (4) 
42 ± 2 (4) 
47 ± 3 (3) 
o ± 0 (3) 
o ± 0 (3) 
2 ± 2 (3) 
o ± 0 (3) 
The data arc taken fro m I of 4 represe ntative experilll ent s. The ep ibolin (Epi) 
and coepibo lin (Coepi) fraction s we re purified as described in Mat"r;"ls "I/(I Methods. 
The specifi ed protein at co ncellt rat io ns ill J.tB g iven ill the parell theses was added 
to D M EM befo re celIs were ad ded. Spread in g is exp ressed as the ave rage nUlllber 
of spread celIs per 100 at tached celI s:!: SEM (number of celIs X 10 - ' ) aft e r 4 h 
incubat ion. USA = bov in e serum album in, I-I SA = human se rul11 albumin , STI 
= soy bean trypsi n inhibi tor. . 
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Table II. Stability of the Coepibo lin Property of Human 
Serum Albumin (HSA) 
HSA T reated % Cell Spreading 
Native 43 ± 2 (25) 
Delipidated 37 ± 4 (12) 
Heated 80°C 10 min 2 ± I (14) 
Freeze-thaw 3 X 36 ± 4 (13) 
Dialyzed 31 ± 2 (13) 
Trypsin trea ted 4 ± 1 (16) 
Urea trea ted 35 ± 1 (5) 
Guanidine HCI treated 38 ± 2 (5) 
DTT treated 20 ± 4 (5) 
NaOH ex posed 0.3 ± 0.3 (3) 
HCI exposed 21 ± 2 (5) 
Cells were added to DMEM contai nin g a li miting co n cellt ration of cpibolin (1 
f.Lg/ml) and I m g/ ml of the treated coep ibo lin preparation (I-ISA). The heated frac-
tions were put in to 3n 80°C W:1[c r bath ror 10 min . The freeze-thaw sa m ples were 
cycled 3 times. The di alyzed sa mples were p laced aga inst a 100 X vo lum e of 10 mM 
Tris-HC I plus 0.85% NaCI pH 8.0 :It 4°C overni g ht. Trypsi n expos ure was per-
formed by addi ng I mg/ l1ll tryps in (S ig ma . crys talline 1'8253) to a 10 Ill g/ ml H SA 
in P-buffer and in cubat ing at 37°C. Afte r I h trypsin \Vas neutralized by additio n 
of I m g/ l11 I soybea n trypsin inhibitor. Del ipidated H SA was purchased (S ig m a 
A3782). This prepa ration is delipidi zed by the m ethod of hen 116 1. In se parate 
experiments an H SA \Vater so lutio n (10 m g/ ml) \Vas ex posed to ure:l (8 M. j. T. 
Baker C hemica l Co .. Phi ll ipsb urg. New Jersey). g uanidine H C I (6 M. Heico. In c .. 
Delaware Gap. Pennsy lvania). dithioth reitol (OTT. 10 m M. Sig m a). NaOH (0. 1 
M). and H C I (0. I M) for 60 min at roo m temperature. The NaOH and HC I ex-
periments were neutralized wi th eq ui va lent HC I and NaOH respectively. and all 
experiments were di:l lyzed aga inst 100 X vo lume of 10 m M Tris- HC I plus 0.85% 
NaC I pH 8.0 at 4°C ove rnig ht. 
RESULTS 
By Gel Filtration Chromatography Coepibolin Activity 
Associates With One Plasma Fraction The gel filtratio n elu-
tion profile of plas m a coepibolin (prepared as described under 
Materials and Methods) is show n in Fig 1. The spreading ac tivity 
of dissociated prim ary g uinea pig epidermal cells was assayed in 
media containin g limiting concentrations of epibolin. Virtu all y 
all the coepibo lin activity associated with th e last eluted pro tein 
pea k (Fig 1, peak C). Coepibolin activity is thus not a nonspecific 
property o f all plas ma proteins. 
Commercial Serum Albumin Contains CoepiboIin Activity 
1n Fig 2 the effect of cell spreading at varying concentrations of 
different proteins is plotted. It is seen th at commercial BSA and 
HSA preparation s arc effective coepibolins. That not all proteins 
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Figure 3. Electroph oretic and antigeni c properties of human serum co-
epibolin fractions. Sa mples of purified coepibolin fract ions iso'lated from 
human plas ma (as described in Materials alld Methods) were reduced (mer-
captoethanol) and run on SDS PAGE [1 3]: protein standards with mo-
lecular weight (in ki lodaltons) to the left (la ll e 1), fraction A50P- l (lalle 
2) , fraction A50P-l D (lml e 3), and human serum albumin (Ca lbiochem) 
(Iaru 4) (lml es 1-4, 10 /-Lg protein per well). Transblot electrophoresis and 
staining with rabbit polyclonal antihuman album in is shown (fraction 
A50P-l , Iml e 5; A50P-l D, lall e 6; and human serum albumin Ca lbiochem 
lalle 7) , (lml es 5-7, 25 /-Lg protein per wel l). 
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Figure 4. Ph otom icrograph of representative nonpobr and polar form s 
of dissociated epiderm al guinea pig cell s. Cel ls were cu ltured fo r 4 h in 
DMEM + epibolin (50 /-Lg/ml) (A, B) and DMEM + epibolin (50 /-L g) 
+ cocpibolin CI mg/ml) (C, 0), stained with Gicmsa [61 Jnd photo-
graphed. A and B, A nonsp rcad cel l and spread ce lls with more than one 
plane of symm etry. C and 0, Spread ce lls with onl y one plane of sy m-
Illetry. Bar = 64 /-Lnl. Giemsa stain. 
are coepibolins is aga in dem o nstrated by the inact ivity of ova l-
bumin (Fig 2) and purifi ed so luble proteins such as commercial 
transferrin, hemoglobin , and STI (Ta ble J). 
The Coepibolin Activity of HSA Is Destroyed by Heat, 
Proteolysis, and Dilute Alkali As shown in Tab le II , th e 
coepi bolin activity of HSA is stabl e to delipidation, freeze-thaw-
in g, dialys is, urea, and g uanidine H C l; it is relatively stable to 
weak red uction or dilute acid , but it is destroyed by hea t, trypsin 
proteolys is, and di lute alkali . 
Coepibolin Activity of Human Plasma Purifies With Al-
bumin As described in detai l abo ve (see Materials and Methods), 
the coepibolin fraction was further purified to electrophoretic 
ho m ogeneity by DEAE Biogel ch romatography at pH 8.0 (l a-
beled fraction ASOP), by Con A Sepharose ch romatog raphy (la-
beled fraction ASOP-I) and by electroelution (labeled fraction ASOP-
1 D). As shown in Fig 3, the purified e1ectroelu ted fraction sta ins 
as a sin gle pro tein species, which has an electrophoretic m obility 
slig htl y fas ter th an commercia ll y prepared albumin but afte r 
tran sblotting shows albumin antigeni city . The difference in mo-
tility is ascribed to preparato ry differences between th e isolated 
(lanes 3 and 6) and the commercial (lanes 4 and 7) preparations, 
and th e difference underscores the described micro heterogeneity 
of albumin preparations [1 7]. C hromatography of the crude co-
epibo lin preparation on B lue Sepharose (Pharmacia) also shows 
that the activity coelu tes w ith albumin (experiments not shown). 
The Presence of Coepibolin Appears to Influence the Shape 
of Spread Cells The sp read in g of cell s in m ed ia containing 
epibolin alone was quantitatively less, but even under hi gh epi-
bohn concentratio ns, qualitatively different fro l11 th at res ulting 
in the presence of epibolin plus coepibo lin. Figure 4 shows the 
representative cellular morphology of dissociated epidermal cells 
in the presence of epibolin alone (Fig 4A,B) or epibo lin plus 
Table III. Po lar Spread Cell s in th e Presence or Absence of a 
Coepibo lin Preparation 
Protein Additive to Medium 
Epi (24) 
Epi (1.2) + BSA (1000) 
Epi (1. 2 + Coepi (1000) 
Polar CellsllOO Spread Cells 
5 ± 1 (8) 
52 ± 2 (8) 
46 ± 3 (4) 
T he conditions of assay were identica l to Table I. A sy nl111 elricall y sprcad cell 
showed llI o rc than o ne pia ne of sy mmetry: pobr sp read cel ls had oll ly o ne pbne 
of sym merry. 
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Figure 5. Spread ing depends on the concomitant presence of epibolin 
and coepibolin. To test whether sequential exposure to epibolin or co-
epibolin is important, cpibolin (1. 25 /-Lg/ml) or BSA (coepibolin) ( I mg/ l1'll) 
was added or removed from a 4-h spreading assay. In all figures the 
abscissa represents time (h) and the ordillale percent of cells spreading. In 
the top fi gures either epiboIin or albu min was added to the dishes pre-
viously containing one of these proteins. The solid lill e indicates cell spread-
ing in the presence of either BSA alone (A) or epiboIin (B). The dashed 
lili es indicate cell spreading in media containing BSA and epibolin alone 
(right). The ({rrOIllS indicate the time of the addition. In the bottom figures 
eithcr epibolin (C) or albumin (D) was removed from dishes containing 
both of these proteins. At the ({ rrOII'S either epibolin (C) or BSA (D) was 
removed . The solid lill e indicates cell spreadin g in media containi llg both 
BSA and epibolin ; and the dashed lilies indicate sprcading in media lacking 
onc of the proteins. Each point represents the average of 2 experiments 
counting 8 x 100 cells (SE less than 10%). 
coepibolin (Fig 4C,D) at 4 h . In epibolin alone the cytoplas m of 
the adherent cells appeared to spread in a more symmetric, often 
radial d istribution. In contrast, cell s spread ing in the presence of 
epibolin plus coepibolin showed an asy mmetric, often polar 
distri bution. The morpho logy of spreading under these two con-
ditions was quantitated by defining a rad ial sp read cell as o ne 
with more than one plane of symmetry (as seen en face) and a 
polar sp read cell as a cell w ith on ly one plane of symmetry. As 
g iven in Ta ble III , the rat io of polar spread cells to tota l number 
of spread cells ill the presence of coepibolin is 10 times more than 
is found in its absence . It is notable that an adherent cell passes 
in time from a radial to a polar form in the process of sp reading 
in vit ro [7J. T hus, this morphologic di fference in the presence or 
absence of coep ibolin may be due to a difference in the mechanism 
of spreading or to the rate of progression through the phases of 
spread ing. At a 24-h time period, however, we have no t found 
that the fraction of polar sp read forms increases in the absence of 
coepibolin (data not shown) ; therefore, it appears likely that the 
mechanisms of cell spreadin g und er these two conditi ons di ffe r. 
THE JO URNAL OF INVESTIGATIVE DERMATOLOGY 
For Maximal Spreading Epibolin and Coepibolin Must Be 
Present Continuously To determine whether continuo us ex-
posure of cell s to epibo lin w ith and w itho ut a coepibolin was 
necessary for maximal spread ing, several experiments were done. 
In one set of experiments, the cells were added to a ti ss ue culture 
dish conta ining defined m ed ium plus BSA (the coepibo lin), and 
at ho url y intervals epibo lin was added (Fig SA). In the second, 
the in verse experim ent, the defined medium contained epibo lin , 
and BSA was added at ho url y intervals (Fig 58). Adding epibolin 
to a BSA-containing dish after 1, 2, o r 3 h resulted in no spreading. 
T his finding is likel y du e to the blockage or epibo lin binding sites 
on the dish by BSA as suggested previo usly [2]. Starting with 
epi bo lin and adding BSA after 1 and 2 h showed a signifi cant 
increase in spread cells by the end of the 4-h incubation period. 
Adding BSA to an epibolin dish after 3 h led to insignifi cant cell 
spreading . In the ex perim en t of Fig 5C and D, cel ls were added 
to defined media containin g bo th epibo lin and coepibolin. At 
hourl y interva ls media were co mpletely replaced with either epi-
bo lin-free (Fig 5C) or coepibo lin-free (Fig 5D) medium, and the 
spread cells were counted after 4 h. As shown, if either protein 
was rem oved at 1 o r 2 h , less than max imal spreadin g was 
obtained . If the proteins were removed at 3 h th e cells spread as 
well as in the undisturbed complete m edi um . T hese studies sug-
gest th at both compo nents o f this system must be present to gether 
for the first 3 h in orde r to achieve m aximal spreading by 4 h 
and that one component does not act before, or independent of, 
the other. H owever , after 3 h in a medium containing both epi-
bolin and coep ibolin cells su bsequentl y spread despite the removal 
of either component. Although the latter could be explained by 
time-dependent protein adh esio n to plasti c, it is also possible that 
the components were inadeq uately removed. T he latter possi-
bility is not favored because remova l of either compo nent at 1 h 
or 2 h (Fig 5C,D) led to less th an maximal spreading . 
DISCUSSION 
From the comparative methods of purifi ca tion , immunologic 
studies \'3], and N-termin al am ino acid seq uence data (K. S. Stenn, 
m anuscript in prepa ration), it appears that epibolin is identical to 
other preparations referred to as serum spreading factor [3], vi-
tronectin [4,18], and S- protein [5,19]. Serum spreading pro tein 
has been found to support the spreadin g of numerous differen-
tiated and transformed animal cell types in serum-free culture 
medium [20]. Studies of epibo lin have been confined to the 
spreading of primary epidermal cells [1 ,2]. In apparent contrast 
to other cell types, primary (i.e., cells not previous ly passaged in 
culture) epiderm al cells require a second plasma component (termed 
coepibolin) in o rder to effect maximal cell spreading. Coepibo lin 
dependence may be either a unique pro perty of epidermal cell s 
o r a property lost after adapta tion to cu lture conditions. 
T he present study was conducted to define some properties of 
the coepibolin component in human plas ma. These studies sug-
ges t (1) that the coepibolin fun ctio n is no t due to protein per se 
but is due to a specific protein within a single plasma fract ion; 
(2) that the coepibolin function is probably associated w ith a 
protein m oiety since it is heat- and protease-sensiti ve; (3) that 
human and bovine coepibolin activity purifies w ith serum al-
bumin; (4) that coepibo lin appears to act conj o intl y and concom-
itantly wi th epibolin ; and (5) that coepibolin influences the mo r-
phology of cell spreadi ng. Because coepibolin activity e1ectroelutes 
with albumin in the Davis PAGE system [11], it is reasonable to 
conclude from the purifi cation studies th at coepibolin activity is 
due to (1) the protein stru cture of albumin or (2) a tightly adherent 
li gand of albumin. In either case coepibolin activ ity is relatively 
stable to denaturants but sensitive to protease and dilute alkali . 
T hese studies do identify the active m o lecular species. 
Earlier studies showed that tumor-promoting phorbo l es ters 
co mpletel y substi tute for coepibolin [21] . Pho rbo l es ters affect 
mu ltiple cellul ar processes, but specifica lly they have been shown 
to produce profound changes in the cytoskeleton [22-26]. In fact , 
phorbol esters have been shown to induce a more spindled or 
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polar morphology in chi ck embryo fibrob lasts remin iscent of the 
coep ibolin effect [24] observed here. 
That coepibolin may ac t li ke the phorbol es ters through pro tein 
kinase C [27 ,28] is an attractive hypothes is currentl y being tested. 
A cril ical readill,e of Iilis II la llll SCripl by Dr. S lI sall Edelslein is g /'(/I~/i"'y ac-
kllolll iedged. 
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